Related Research Articles
Pfizer Inc. is an American multinational pharmaceutical corporation. Pfizer is one of the world's largest pharmaceutical companies, and was ranked 64th on the 2020 Fortune 500 list of the largest U.S. corporations by total revenue, at $47.644 billion as of December 31, 2020.
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi.
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-Astrazeneca COVID-19 vaccine.
Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.
Gold Bond is a brand of over-the-counter skin care products produced by Chattem of Chattanooga, Tennessee, now a subsidiary of the French pharmaceutical company Sanofi. It is available as both a powder and a topical cream. Gold Bond is used to curb moisture, control odor, and soothe minor skin irritations, notably jock itch. Spin-off products are designed for specific uses, such as foot powders or powders for infants to treat diaper rash.
Paul Rudd Drayson, Baron Drayson FREng PC, is a British businessman, amateur racing driver and Labour politician. He was Minister of Science in the Department for Business, Innovation and Skills until May 2010, where he replaced Ian Pearson. In June 2009 he was additionally appointed as Minister of State for Strategic Defence Acquisition Reform at the Ministry of Defence. After losing his ministerial positions in the General Election 2010 he decided to devote himself totally towards his motorsports company Drayson Racing Technology. He is chairman and CEO of Drayson Technologies Ltd.
LloydsPharmacy is a British pharmacy company, with more than 1,500 pharmacies. It has around 17,000 staff and dispenses over 150 million prescription items annually. It is owned by the German company Celesio, formerly GEHE AG, which is in turn owned by the American McKesson Corporation.
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991.
Seth Franklin Berkley, is an American medical epidemiologist, the CEO of the GAVI Alliance and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI).
Oxford University Innovation Limited (OUI) is a British technology transfer and consultancy company created to manage the research and development (R&D) of University spin-offs. OUI is a wholly owned subsidiary of the University of Oxford, and is located on Botley Road, Oxford, England. OUI was previously known as Isis Innovation (1988–2016) and Oxford University Research and Development Ltd (1987–1988).
Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.
Mark A. F. Kendall is an Australian biomedical engineer, inventor, scientist and entrepreneur.
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company developing a universal influenza vaccine called M-001. BiondVax is a publicly traded company, listed on the NASDAQ. The vaccine technology was invented in the 1990s at the Weizmann Institute of Science in the laboratory of Ruth Arnon, and was licensed to BiondVax in 2003.
Clive Jacobs is a British businessman and entrepreneur. He is the founder of Holiday Autos Group and Travel Weekly Group.
Brian J. Bellhouse was a British academic, engineer, and entrepreneur, the inventor of PowderJect, a needle-free injection system for delivering medications and vaccines. He was also a professor at the University of Oxford.
Barkat Pharmaceutical Group is an Iranian Pharmaceutical public company, which was founded in 2010, named Tadbir innovation pharmaceutical company. The company provides services through cooperation between science-based institutions and scientists based on medicine around the world. It supplies 14 percent of all the country's essential drugs through its 25 subsidiaries. The company produces 700 kinds of products in the pharmaceutical sector and offers it internally. The Barkat Pharmaceutical Group has established as the first specialized drug and pharmaceutical research center in Iran, also it has been developed by constructing advanced pharmaceutical factories, called Barkat Pharmaceutical Town. The Barkat group complies with all common pharmaceutical standards such as the FDA, WHO, EMEA. "Cell therapy", production of "peptide medications", "research, development and processing of medicinal plants," the creation of the "Museum of Iranian-Islamic Medicine" as well as "Solids and Semi-Solids" projects are the main activities of the Group.
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.
Brian Griffin is a British photographer. His portraits of 1980s pop musicians lead to him being named the "photographer of the decade" by The Guardian in 1989. His work is held in the permanent collections of the Arts Council, British Council, Victoria and Albert Museum and National Portrait Gallery, London.
References
- ↑ Elliott, Francis (14 April 2002). "Labour donor is no stranger to controversy". Telegraph. Retrieved 29 June 2017.CS1 maint: discouraged parameter (link)
- ↑ Andrew Clark (19 January 2002). "Interview: Paul Drayson, Powderject Pharmaceuticals | Business". The Guardian . Retrieved 29 June 2017.CS1 maint: discouraged parameter (link)
- 1 2 Fletcher, Richard (27 April 2003). "PowderJect to be sold for £500m". Daily Telegraph . UK. Retrieved 27 June 2017.CS1 maint: discouraged parameter (link)
- 1 2 3 Geoffrey Gibbs (20 May 2003). "£43m windfall for PowderJect chief | Business". The Guardian . Retrieved 27 June 2017.CS1 maint: discouraged parameter (link)